AI-assisted DIMS glasses to stop myopia in young children with pre-myopia
Official title: Managing Premyopia in Chinese Children Using Artificial Intelligence Assisted Defocus Incorporated Multiple Segments Based Spectacle Lens: a Randomized Controlled Clinical Trial
Run by Shanghai Eye Disease Prevention and Treatment Center · NCT07765550 · Data updated 2026-11-12
This trial tests whether AI-assisted DIMS-style glasses can help prevent myopia in children aged 3–6 who are at risk.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 3 Years to 6 Years |
| Sex | All |
| Enrollment | 128 (estimated) |
| Sponsor | Shanghai Eye Disease Prevention and Treatment Center Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | September 12, 2026 |
| Main results expected | May 31, 2028 |
| Study ends | August 31, 2028 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07765550 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 3–6 years old with hyperopic reserve between >-0.50 D and ≤+0.75 D, low cylindrical error, anisometropia ≤1.5 D, and at least one parent with SER ≤ -3.00 D.
✕Probably not a fit
Some children may not experience slowed progression due to individual variation or non-compliance with lens wear.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a parallel-design, open-label, randomized controlled trial conducted at a single center in Shanghai. Children aged 3–6 with low hyperopic reserve will be assigned to receive AI-assisted defocus-incorporated multi-segment spectacle lenses or control treatment, to see if myopia progression can be slowed or prevented. The study uses AI-powered optimization of lens defocus in the DIMS framework and includes safety monitoring and standard refractive outcomes. A secondary component includes smartwatches to support adherence and monitoring of visual behaviors.
Why it matters
Potential benefit: If successful, children receiving the AI-assisted DIMS lenses may have a lower risk of progressing toward myopia.
How similar studies have gone: Prior DIMS-style approaches have shown promise in delaying myopia onset/progression; this AI-enhanced approach is a novel refinement.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 3 and 6 years (inclusive), regardless of gender or ethnicity. * Cycloplegic spherical equivalent refraction (SER) of the worse eye \> -0.50 D and ≤ +0.75 D, absolute cylindrical power ≤ 1.0 D, anisometropia ≤ 1.5 D. * Best corrected monocular distance high contrast VA ≥ 0.5 for ages 3-5; ≥ 0.7 for age 6. * At least one parent with SER ≤-3.00D Exclusion Criteria: * Individuals with any ocular or systemic diseases that may affect vision and refractive development (e.g., keratoconus, abnormalities in lens shape or position, Marfan syndrome, retinopathy of prematurity, etc.). * Individuals with known allergies or contraindications to cycloplegic agents. * Previous use of myopia management treatment (spectacles, atropine; CLs). * Individuals with binocular vision abnormalities: manifest strabismus, monocular suppression, abnormal fusion function, or impaired stereopsis. * Individuals unable to cooperate with examinations or communicate. * Any other conditions deemed by the investigator as unsuitable for participation in the study.
Where it's running
-
Shanghai Eye Disease Prevention and Treatment Center
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Principal investigator: He, Prof — Shanghai Eye Disease Prevention and Treatment Center
- Study coordinator: Xiangui He, Prof
- Email: xianhezi@163.com
- Phone: +86 15000755422
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventing early childhood myopia with special spectacle lenses and low-dose atropine
This project will try spectacle lenses with highly aspherical lenslets and low-dose (0.01% and 0.05%) atropine eye drops to see if they slow myopia progression in children aged 3–6.
-
Virtual Far-sight Reading Device for Pre-myopia in Children
A device-guided reading program is tested to see if it can slow or prevent myopia in kids with pre-myopia and if it's safe with daily use for up to 6 months.
-
Evaluating a device for screening vision problems in young children
This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.
-
Optimizing light exposure to prevent and control myopia in children
This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.
-
Hyperopic reserve screening for kindergartners in Beijing
A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.
-
Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses
This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.